Search Results

You are looking at 1 - 10 of 166 items for :

  • Graves��� hyperthyroidism x
Clear All
Free access

Earn H. Gan, Anna L. Mitchell, Ruth Plummer, Simon Pearce, and Petros Perros

by thyroid disorders. This report describes a case of Graves hyperthyroidism after 8 years of tremelimumab therapy. We speculate a causal relationship between tremelimumab therapy and the development of Graves disease, and highlight the importance

Free access

Elena Sabini, Ilaria Ionni, Roberto Rocchi, Paolo Vitti, Claudio Marcocci, and Michele Marinò

deterioration of Graves’ orbitopathy in patients with Graveshyperthyroidism. A similar release of autoantigens may occur at the eye level resulting in the development of Graves’ orbitopathy. What Does This Case Report Add? To our knowledge

Free access

Alan Chun Hong Lee and George J. Kahaly

Introduction Graves’ disease (GD) accounts for 75% of hyperthyroidism in iodine-replete geographical areas. Approximately one-fifth of GD patients develop Graves’ orbitopathy (GO), which is the most common extrathyroidal manifestation of GD

Free access

Allan Carlé, Nils Knudsen, Torben Jørgensen, Bettina Thuesen, Jesper Karmisholt, Stine Linding Andersen, and Inge Bülow Pedersen

studies [ 5 ], have shown a lower risk during pregnancy of developing autoimmune thyroid disease such as Graveshyperthyroidism and autoimmune hypothyroidism. Due to the so called “rebound phenomenon,” the risk of autoimmune thyroid disease after delivery

Open access

Meihua Jin, Ahreum Jang, Chae A Kim, Tae Young Kim, Won Bae Kim, Young Kee Shong, Min Ji Jeon, and Won Gu Kim

Introduction Graveshyperthyroidism is an autoimmune disease in which thyrotropin (thyroid-stimulating hormone (TSH)) receptor antibody (TRAb) stimulates thyroid follicular cells, resulting in thyrotoxicosis and enlargement of the thyroid

Free access

George J. Kahaly, Luigi Bartalena, Lazlo Hegedüs, Laurence Leenhardt, Kris Poppe, and Simon H. Pearce

hyperthyroidism is 1.2–1.6, 0.5–0.6 overt and 0.7–1.0% subclinical [ 1 , 5 ]. The most frequent causes are Graves’ disease (GD) and toxic nodular goiter. GD is the most prevalent cause of hyperthyroidism in iodine-replete geographical areas, with 20–30 annual

Free access

Roberto Negro, Laszlo Hegedüs, Roberto Attanasio, Enrico Papini, and Kristian H. Winther

. 2017 Oct ; 24 ( 5 ): 348 – 55 . 10.1097/MED.0000000000000356 28639965 1752-296X 19 Kahaly GJ , Riedl M , König J , Diana T , Schomburg L . Double-Blind, Placebo-Controlled, Randomized Trial of Selenium in Graves Hyperthyroidism

Free access

Tetsuya Mizokami, Katsuhiko Hamada, Tetsushi Maruta, Kiichiro Higashi, and Junichi Tajiri

What Is Known about This Topic? • Anterior neck pain and fever, caused by radiation thyroiditis, is a rare occurrence after 131 I therapy for Graves' hyperthyroidism. In addition, the ultrasonographic findings have not been well described

Open access

J Karmisholt, S L Andersen, I Bulow-Pedersen, A Krejbjerg, B Nygaard, and A Carlé

Introduction Graveshyperthyroidism (GH) is an autoimmune disease mainly affecting the thyroid gland ( 1 , 2 ). The disease is usually transient with remission occurring within a period of 1–2 years after treatment with anti-thyroid drugs

Free access

Shakeel Kautbally, Orsalia Alexopoulou, Chantal Daumerie, François Jamar, Michel Mourad, and Dominique Maiter

Group 1996: Thyroid-associated ophthalmopathy after treatment for Graveshyperthyroidism with antithyroid drugs or iodine-131. J Clin Endocrinol Metab 2009;94:3700–3707. 10.1210/jc.2009-0747 5 Laurberg P, Wallin G, Tallstedt L, Abraham